Kenneth d'Entremont - Net Worth and Insider Trading

Kenneth d'Entremont Net Worth

The estimated net worth of Kenneth d'Entremont is at least $1 Million dollars as of 2024-11-11. Kenneth d'Entremont is the Director, Senior Officer of Medexus Pharmaceuticals Inc and owns about 643,889 shares of Medexus Pharmaceuticals Inc (TSX:MDP) stock worth over $1 Million. Details can be seen in Kenneth d'Entremont's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth d'Entremont has not made any transactions after 2023-06-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kenneth d'Entremont

To

Kenneth d'Entremont Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kenneth d'Entremont owns 1 companies in total, including Medexus Pharmaceuticals Inc (TSX:MDP) .

Click here to see the complete history of Kenneth d'Entremont’s form 4 insider trades.

Insider Ownership Summary of Kenneth d'Entremont

Ticker Comapny Transaction Date Type of Owner
TSX:MDP Medexus Pharmaceuticals Inc 2023-06-29 Director & Senior Officer

Kenneth d'Entremont Latest Holdings Summary

Kenneth d'Entremont currently owns a total of 1 stock. Kenneth d'Entremont owns 643,889 shares of Medexus Pharmaceuticals Inc (TSX:MDP) as of June 29, 2023, with a value of $1 Million.

Latest Holdings of Kenneth d'Entremont

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:MDP Medexus Pharmaceuticals Inc 2023-06-29 643,889 2.17 1,397,239

Holding Weightings of Kenneth d'Entremont


Kenneth d'Entremont Form 4 Trading Tracker

According to the SEC Form 4 filings, Kenneth d'Entremont has made a total of 30 transactions in Medexus Pharmaceuticals Inc (TSX:MDP) over the past 5 years, including 28 buys and 2 sells. The most-recent trade in Medexus Pharmaceuticals Inc is the acquisition of 3,800 shares on June 29, 2023, which cost Kenneth d'Entremont around $6,346.

Insider Trading History of Kenneth d'Entremont

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kenneth d'Entremont Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kenneth d'Entremont Ownership Network

Ownership Network List of Kenneth d'Entremont

No Data

Ownership Network Relation of Kenneth d'Entremont

Insider Network Chart

Kenneth d'Entremont Owned Company Details

What does Medexus Pharmaceuticals Inc do?

Who are the key executives at Medexus Pharmaceuticals Inc?

Kenneth d'Entremont is the Director & Senior Officer of Medexus Pharmaceuticals Inc. Other key executives at Medexus Pharmaceuticals Inc include Senior Officer Brendon Buschman , Senior Officer Marcel Pascal Konrad , and Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6) Brian Peters .

Medexus Pharmaceuticals Inc (TSX:MDP) Insider Trades Summary

Over the past 18 months, Kenneth d'Entremont made 2 insider transaction in Medexus Pharmaceuticals Inc (TSX:MDP) with a net purchase of 18,800. Other recent insider transactions involving Medexus Pharmaceuticals Inc (TSX:MDP) include a net purchase of 20,000 shares made by Brendon Buschman , a net purchase of 7,000 shares made by Mike Mueller , and a net purchase of 93,800 shares made by Stephen William Nelson .

In summary, during the past 3 months, insiders sold 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) were sold and 147,900 shares were bought by its insiders, resulting in a net purchase of 147,900 shares.

Medexus Pharmaceuticals Inc (TSX:MDP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Medexus Pharmaceuticals Inc Insider Transactions

No Available Data

Kenneth d'Entremont Mailing Address

Above is the net worth, insider trading, and ownership report for Kenneth d'Entremont. Currently GuruFocus does not have mailing address information for Kenneth d'Entremont.